27 June 2013 
EMA/355023/2014  
Committee for Medicinal Products for Human Use (CHMP) 
Assessment report under Article 46 
Infanrix hexa  
International non-proprietary name: diphtheria (d), tetanus (t), pertussis 
(acellular, component) (pa), hepatitis b (rdna) (hbv), poliomyelitis 
(inactivated) (ipv) and haemophilus influenzae type b (hib) conjugate 
vaccine (adsorbed) 
Procedure No. EMEA/H/C/000296/P46/099.1 
Note 
Variation assessment report as adopted by the CHMP with all information of a commercially 
confidential nature deleted. 
30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom 
Telephone  +44 (0)20 3660 6000  Facsimile +44 (0)20 3660 5555 
Send a question via our website www.ema.europa.eu/contact 
An agency of the European Union   
© European Medicines Agency, 2014. Reproduction is authorised provided the source is acknowledged. 
 
 
  
 
 
 
 
 
 
 
